{"count":16,"next":null,"previous":null,"results":[{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Expert list","Illumina TruGenome Clinical Sequencing Services"],"phenotypes":["Left Ventricular Noncompaction Cardiomyopathy"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","tags":[],"panel":{"id":238,"hash_id":"55a38d3a22c1fc64c2942434","name":"Left Ventricular Noncompaction Cardiomyopathy","disease_group":"Cardiovascular disorders","disease_sub_group":"Cardiomyopathy","status":"public","version":"1.3","version_created":"2019-06-20T15:15:12.623782Z","relevant_disorders":[],"stats":{"number_of_genes":16,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Emory Genetics Laboratory"],"phenotypes":[],"mode_of_inheritance":"","tags":[],"panel":{"id":267,"hash_id":"5548cc07bb5a16250cc22015","name":"Hyperammonaemia","disease_group":"Metabolic disorders","disease_sub_group":"Urea Cycle disorders","status":"public","version":"1.8","version_created":"2017-11-05T02:37:20.328985Z","relevant_disorders":[],"stats":{"number_of_genes":106,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["South West GLH","Expert Review Green","Illumina TruGenome Clinical Sequencing Services","Emory Genetics Laboratory"],"phenotypes":["Dilated Cardiomyopathy, X-Linked"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":47,"hash_id":"55a4d99022c1fc6710839b84","name":"Dilated Cardiomyopathy and conduction defects","disease_group":"Cardiovascular disorders","disease_sub_group":"Cardiomyopathy","status":"public","version":"1.63","version_created":"2019-09-30T12:02:00.646768Z","relevant_disorders":["Dilated Cardiomyopathy","Dilated Cardiomyopathy (DCM)","Dilated cardiomyopathy - teen and adult"],"stats":{"number_of_genes":84,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":null,"publications":[],"evidence":["NHS GMS","North West GLH","London North GLH","IUIS Classification February 2018","Victorian Clinical Genetics Services","Expert Review Green","ESID Registry 20171117","GRID V2.0","Congenital neutropaenia v1.22"],"phenotypes":["Barth syndrome","Cardioskeletal myopathy with neutropenia and abnormal mitochondria","3-methylglutaconic aciduria, type II, 302060","Cardiomyopathy, myopathy, growth retardation, neutropenia","Congenital defects of phagocyte number or function"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":398,"hash_id":null,"name":"Primary immunodeficiency","disease_group":"","disease_sub_group":"","status":"public","version":"1.132","version_created":"2019-09-27T14:37:49.085568Z","relevant_disorders":["Primary immunodeficiency disorders","A- or hypo-gammaglobulinaemia","Congenital neutropaenia","Agranulocytosis","Combined B and T cell defect","Inherited complement deficiency","SCID","Primary immune disorder","Primary immunodeficiency","A-gammaglobulinaemia","Agammaglobulinaemia","hypo-gammaglobulinaemia","hypogammaglobulinemia","immune deficiency syndromes","Severe combined immunodeficiency","Congenital neutopenia","Familial haemophagocytic lymphohistiocytic disorders","Familial hemophagocytic lymphohistiocytic disorders","PID","Sepsis","Disseminated non-tuberculous mycobacterial infection","R15"],"stats":{"number_of_genes":395,"number_of_strs":0,"number_of_regions":2},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","UKGTN"],"phenotypes":["Barth syndrome\t302060"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":159,"hash_id":"58a70e858f62037e8779b2e8","name":"Cytopenias and congenital anaemias","disease_group":"Haematological disorders","disease_sub_group":"Anaemias and red cell disorders","status":"public","version":"1.73","version_created":"2019-09-23T11:25:32.403071Z","relevant_disorders":["Aplastic anaemia with or without paroxysmal nocturnal haemoglobinuria","Apparent aplastic anaemia or paroxysmal nocturnal haemoglobinuria","Congenital anaemias","Early onset pancytopenia and red cell disorders","Anaemias and red cell disorders","Cytopaenias and congenital anaemias","Cytopenia and pancytopenia"],"stats":{"number_of_genes":219,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["9345098","9382096"],"evidence":["North West GLH","Yorkshire and North East GLH","London South GLH","NHS GMS","Expert Review Green","Wessex and West Midlands GLH"],"phenotypes":["Barth syndrome, 302060","302060 Barth syndrome"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":519,"hash_id":null,"name":"Cytopenia - NOT Fanconi anaemia","disease_group":"","disease_sub_group":"","status":"public","version":"0.120","version_created":"2019-09-23T10:29:43.892929Z","relevant_disorders":["R91","R258"],"stats":{"number_of_genes":84,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["27604308"],"evidence":["Expert Review Green","Literature"],"phenotypes":["Methylglutaconic aciduria type II, Barth syndrome (Organic acidurias)","Disorders of mitochondrial membrane lipids (Mitochondrial respiratory chain disorders (caused by nuclear variants only))","Disorders of mitochondrial lipid metabolism","Barth syndrome, 302060"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":302,"hash_id":"5763f1518f620350a22bccdb","name":"Undiagnosed metabolic disorders","disease_group":"Metabolic disorders","disease_sub_group":"Specific metabolic abnormalities","status":"public","version":"1.373","version_created":"2019-10-08T14:47:17.153678Z","relevant_disorders":["Undiagnosed Metabolic Panel"],"stats":{"number_of_genes":744,"number_of_strs":1,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308"],"evidence":["London North GLH","NHS GMS","Expert Review Green"],"phenotypes":["Disorders of mitochondrial membrane lipids (Mitochondrial respiratory chain disorders (caused by nuclear variants only))","Barth syndrome, 302060","Methylglutaconic aciduria type II, Barth syndrome (Organic acidurias)","Disorders of mitochondrial lipid metabolism"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":467,"hash_id":null,"name":"Inborn errors of metabolism","disease_group":"","disease_sub_group":"","status":"public","version":"1.348","version_created":"2019-10-09T08:19:52.386941Z","relevant_disorders":["Likely inborn error of metabolism - targeted testing not possible"],"stats":{"number_of_genes":877,"number_of_strs":2,"number_of_regions":1},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["NHS GMS","Expert Review Green"],"phenotypes":["Barth syndrome, 302060"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":539,"hash_id":null,"name":"Possible mitochondrial disorder - nuclear genes","disease_group":"","disease_sub_group":"","status":"public","version":"1.12","version_created":"2019-09-16T14:57:01.996850Z","relevant_disorders":["R63"],"stats":{"number_of_genes":374,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["PAGE DD-Gene2Phenotype","Expert Review Green"],"phenotypes":["BARTH SYNDROME"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":478,"hash_id":null,"name":"Fetal anomalies","disease_group":"","disease_sub_group":"","status":"public","version":"0.344","version_created":"2019-09-17T09:38:10.568007Z","relevant_disorders":["R21"],"stats":{"number_of_genes":1721,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["8630491"],"evidence":["DD-Gene2Phenotype","Expert Review Green"],"phenotypes":["BARTH SYNDROME 302060"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":484,"hash_id":null,"name":"DDG2P","disease_group":"","disease_sub_group":"","status":"public","version":"1.137","version_created":"2019-10-08T15:56:59.220133Z","relevant_disorders":[],"stats":{"number_of_genes":1893,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["NHS GMS","South West GLH","Emory Genetics Laboratory"],"phenotypes":["Cardiomyopathy"],"mode_of_inheritance":"","tags":[],"panel":{"id":85,"hash_id":"55ad205422c1fc7041340234","name":"Hereditary neuropathy","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Motor and Sensory Disorders of the PNS","status":"public","version":"1.333","version_created":"2019-07-09T13:10:50.031506Z","relevant_disorders":["Charcot-Marie-Tooth disease"],"stats":{"number_of_genes":276,"number_of_strs":11,"number_of_regions":2},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["8630491"],"evidence":["Expert Review Green"],"phenotypes":["BARTH SYNDROME","BTHS"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":285,"hash_id":"558aa423bb5a16630e15b63c","name":"Intellectual disability","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodevelopmental disorders","status":"public","version":"2.1065","version_created":"2019-10-07T13:42:16.019766Z","relevant_disorders":["Coarse facial features including Coffin-Siris-like disorders","ID","Moderate","severe or profound intellectual disability","Schizophrenia plus additional features","Intellectual disability - microarray","fragile X and sequencing"],"stats":{"number_of_genes":2253,"number_of_strs":11,"number_of_regions":57},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Victorian Clinical Genetics Services","Expert Review Green","Radboud University Medical Center, Nijmegen","Expert list","Expert"],"phenotypes":["Disorders of mitochondrial lipid metabolism","Barth syndrome, 302060"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":112,"hash_id":"55928cf522c1fc4f7d26e960","name":"Mitochondrial disorders","disease_group":"Metabolic disorders","disease_sub_group":"Mitochondrial","status":"public","version":"2.1","version_created":"2019-10-01T15:59:44.993681Z","relevant_disorders":["Lactic acidosis","All recognised syndromes and those with suggestive features"],"stats":{"number_of_genes":467,"number_of_strs":2,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308"],"evidence":["South West GLH","London South GLH","MetBioNet","Expert Review Green","MetBioNet","London South GLH","South West GLH","Expert Review Green"],"phenotypes":["Disorders of mitochondrial lipid metabolism","Dilated Cardiomyopathy, X-Linked","Neutropenia, muscle weakness, growth retardation","Non-compaction cardiomyopathy","Barth syndrome, 302060","Left Ventricular Noncompaction Cardiomyopathy","HCM, mixed","Disorders of mitochondrial membrane lipids (Mitochondrial respiratory chain disorders (caused by nuclear variants only))","Barth syndrome","Methylglutaconic aciduria type II, Barth syndrome (Organic acidurias)"],"mode_of_inheritance":"BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","tags":[],"panel":{"id":749,"hash_id":null,"name":"Cardiomyopathies - including childhood onset","disease_group":"","disease_sub_group":"","status":"public","version":"0.13","version_created":"2019-09-16T12:01:25.928956Z","relevant_disorders":["Paediatric or syndromic cardiomyopathy","R135"],"stats":{"number_of_genes":180,"number_of_strs":0,"number_of_regions":1},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["BTHS","XAP-2","G4.5","TAZ1"],"biotype":"protein_coding","hgnc_id":"HGNC:11577","gene_name":"tafazzin","omim_gene":["300394"],"alias_name":["Barth syndrome"],"gene_symbol":"TAZ","hgnc_symbol":"TAZ","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:153639854-153650065","ensembl_id":"ENSG00000102125"}},"GRch38":{"90":{"location":"X:154411518-154421726","ensembl_id":"ENSG00000102125"}}},"hgnc_date_symbol_changed":"1989-05-29"},"entity_type":"gene","entity_name":"TAZ","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308"],"evidence":["London South GLH","Expert Review Green","London South GLH","Expert Review Green"],"phenotypes":["Disorders of mitochondrial lipid metabolism","Dilated Cardiomyopathy, X-Linked","Barth syndrome, 302060","Methylglutaconic aciduria type II, Barth syndrome (Organic acidurias)","Left Ventricular Noncompaction Cardiomyopathy","Disorders of mitochondrial membrane lipids (Mitochondrial respiratory chain disorders (caused by nuclear variants only))"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","tags":[],"panel":{"id":750,"hash_id":null,"name":"Sudden cardiac death","disease_group":"","disease_sub_group":"","status":"public","version":"0.10","version_created":"2019-09-24T10:05:54.784946Z","relevant_disorders":["Molecular autopsy","R138"],"stats":{"number_of_genes":119,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}}]}